This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study sample
No power calculations to determine the sample size were reported and no specific sample size was planned. A convenience sample of 48 patients was recruited from North Tyneside Healthcare Trust. The patients were recruited from Podiatry services, and by means of referrals from physicians and physiotherapists. Out of the 48 patients, 22 patients received accommodative orthoses and 26 received functional orthoses. The mean age of patients in the accommodative group was 58.3 (+/-12.6) years and in the functional group was 61.2 (+/-14.4) years.
Study design
The study was a randomised trial carried out in a single centre. Patients were randomly assigned to one of the two groups by the use of randomised tables by an independent observer. Patients were followed-up for a period of eight weeks. Thirteen patients were lost to follow-up, an attrition rate of 27.1%. Out of the thirteen patients, 9 patients were given an accommodative orthosis and 4 were issued with a functional orthosis. No significant difference was noted between the two dropout groups.
Analysis of effectiveness
It would appear that the analysis of the clinical study was based on treatment completers only. The outcome used in the study was health status. Health status measures were obtained using the Foot Health Status Questionnaire (FHSQ) and the EuroQol (EQ5D) questionnaire. The FHSQ is a disease-specific questionnaire that captures foot health-related quality-of-life data, and has 13 key items spanning four domains of foot health: foot pain, foot function, footwear, and general foot health. A maximum score of 100 signifies optimal foot health. The EQ5D is a generic questionnaire used to measure health status. It comprises five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension comprises three levels (some problems, moderate problems, and extreme problems), generating 243 theoretically possible health states. These two questionnaires were given to patients at baseline, at 4 weeks and at 8 weeks. Both groups were shown to be comparable in terms of age, weight, height, body mass index, and duration of plantar heel pain.
Effectiveness results
Using the FHSQ, no significant differences were found for either orthosis at the time intervals for the general foot health and footwear domains.
The foot pain domain demonstrated a significant difference at all time intervals for the functional orthosis (p<0.05). At baseline the FHSQ foot pain score was 39 (+/-18.7), at 4 weeks was 54 (+/-21.9) and at 8 weeks was 74 (+/-25.3).
The accommodative orthosis demonstrated a significant difference between baseline and 4 and 8 weeks (p<0.05) but not between 4 and 8 weeks (p=0.53). At baseline the FHSQ foot pain score was 30 (+/-23.7), at 4-weeks was 62 (+/-24.1) and at 8-weeks was 62 (+/-26.1).
Significant differences were noted in the FHSQ foot-function domain for the functional orthosis group between baseline and 4 and 8 weeks (p<0.05). At baseline the FHSQ foot-function score was 54 (+/-24.7), at 4 weeks was 71 (+/-19.3) and at 8 weeks was 74 (+/-25.4). No significant differences were observed for the accommodative orthosis group during the 8-week trial (p>0.05).
No significant differences in EQ5D scores at the different time intervals were found for the accommodative orthosis group. However, significant differences (p<0.05) were observed for the functional orthosis group between baseline and 8 weeks and between 4 and 8 weeks. At baseline the EQ5D score was 0.62 (+/-0.25), at 4 weeks it was 0.68 (+/-0.19) and at 8 weeks was 0.79 (+/-0.11).
Clinical conclusions
The results of this feasibility study indicated that there was an improvement over time in the FHSQ foot-pain and footfunction domain scores and the EQ5D scores following the intervention of functional orthoses over a 2-month period.
The accommodative foot orthoses demonstrated a significant reduction in foot pain only at 4 weeks.
Measure of benefits used in the economic analysis
The measure of benefits used in the economic analysis was quality-adjusted life-years (QALYs) gained. Results from the EQ5D scores at baseline and at 4 and 8 weeks were converted to a utility score, based on a "tariff" derived from interviews with 3,395 members of the UK public. The two orthosis groups were compared in terms of mean changes in QALYs during the 8-week period by plotting the EQ5D utility scores at baseline and at 8 weeks and calculating the area under the curve to estimate QALYs gained/lost for each patient.
Direct costs
Resource quantities and costs were not reported separately. However, the authors did provide unit costs for each item of resource use. The direct costs included in the analysis were those to the National Health Service and those accrued by the patient and the family. These included the following items: the cost of the orthoses to the NHS; clinician costs; the travel and time (from the clinician's base of work to the patient's residence) costs of the clinician; patient's cost of travel time to and from appointments; patient's time; patients' travel expenses; other expenses incurred by the patient as a direct result of treatment; and the costs to any other NHS departments, including use of physician or physiotherapy services during the study. Data on resource use for the economic analysis were obtained from patient and staff questionnaires (both distributed at baseline and at 4 and 8 weeks). Discounting was not relevant, as all costs were incurred over a period of two months and it was, appropriately, not performed. The study reported average costs. Costs were inflated to a 2001-2002 price base using the National Health Service Cost Index.
Statistical analysis of costs
The overall total mean cost per patient was analysed using the Mann-Whitney U test. Statistical significance was set at p<0.05.
Indirect Costs
The indirect costs were not included in the analysis.
Currency
UK pounds sterling (). The conversion rate to US dollars was reported as 1 = $1.82.
Sensitivity analysis
No sensitivity analyses were conducted.
Estimated benefits used in the economic analysis
The mean QALY gain was represented as a monthly difference. The mean QALY gain per month was 0.0488 for the functional orthosis group and 0.0379 for the accommodative orthosis group. The authors noted that these differences were small and did not approach conventional level of statistical significance.
Cost results
There was a significant difference in mean total costs for the accommodative orthosis group versus the functional orthosis group: 16.18 (+/-5.54) versus 34.17 (+/-5.18), (p<0.05). The 95% confidence intervals (CIs) demonstrated that the mean difference was between 21.79 and 14.17 per patient.
